Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia.

MLA

Camou, Fabrice, et al. “Feasibility of Convalescent Plasma Therapy in Severe COVID-19 Patients with Persistent SARS-CoV-2 Viremia.” Journal of Medical Virology, vol. 93, no. 9, Sept. 2021, pp. 5594–98. EBSCOhost, https://doi.org/10.1002/jmv.27032.

APA

Camou, F., Tinevez, C., Beguet-Yachine, M., Bellecave, P., Ratiarison, D., Tumiotto, C., Lafarge, X., Guisset, O., Mourissoux, G., Lafon, M.-E., Bonnet, F., & Issa, N. (2021). Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia. Journal of Medical Virology, 93(9), 5594–5598. https://doi.org/10.1002/jmv.27032

Chicago

Camou, Fabrice, Claire Tinevez, Mathilde Beguet-Yachine, Pantxika Bellecave, Diana Ratiarison, Camille Tumiotto, Xavier Lafarge, et al. 2021. “Feasibility of Convalescent Plasma Therapy in Severe COVID-19 Patients with Persistent SARS-CoV-2 Viremia.” Journal of Medical Virology 93 (9): 5594–98. doi:10.1002/jmv.27032.